Epidermal growth factor: effects of androgens and adrenergic agents.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D000941:Antigens; D003994:Bucladesine / Q000494:pharmacology; D000242:Cyclic AMP / Q000494:pharmacology; D004558:Electric Stimulation; D004837:Epinephrine / Q000494:pharmacology*; D005725:Ganglia, Autonomic / Q000502:physiology; D006133:Growth Substances / Q000097:blood / Q000378:metabolism* / Q000652:urine; D008297:Male; D051379:Mice; D008892:Milk / Q000032:analysis; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011863:Radioimmunoassay; D012463:Saliva / Q000032:analysis; D012737:Sex Factors; D012867:Skin / Q000187:drug effects / Q000254:growth & development*; D013363:Submandibular Gland / Q000378:metabolism*; D013739:Testosterone / Q000494:pharmacology*
D000941:Antigens; D006133:Growth Substances; D010643:Phenoxybenzamine; D000804:Angiotensin II; D010656:Phenylephrine; D013739:Testosterone; D003994:Bucladesine; D000242:Cyclic AMP; D004837:Epinephrine; D010646:Phentolamine